Clinical features of patients with primary ocular adnexal lymphoma
Characteristic . | All . | EMZL . | Non-EMZL . |
|---|---|---|---|
| No. of patients | 62 | 55 | 7 |
| Age, y | |||
| Median | 65 | 66 | 59 |
| Range | 30-92 | 30-92 | 49-91 |
| Sex, no. male/no. female | 42/20 | 35/20 | 7/0 |
| Involved sites, no. | |||
| Orbital | 33 | 26 | 7 |
| Conjunctivae | 16 | 16 | 0 |
| Lacrimal apparatus | 13 | 13 | 0 |
| Stage, no. | |||
| I | 53 | 46 | 7 |
| II | 2 | 2 | 0 |
| III | 0 | 0 | 0 |
| IV | 7 | 7 | 0 |
| Histologic category, no. | |||
| EMZL | 55 | 55 | NA |
| SLL | 2 | NA | 2 |
| DLBCL | 2 | NA | 2 |
| Undetermined | 3 | NA | 3 |
Characteristic . | All . | EMZL . | Non-EMZL . |
|---|---|---|---|
| No. of patients | 62 | 55 | 7 |
| Age, y | |||
| Median | 65 | 66 | 59 |
| Range | 30-92 | 30-92 | 49-91 |
| Sex, no. male/no. female | 42/20 | 35/20 | 7/0 |
| Involved sites, no. | |||
| Orbital | 33 | 26 | 7 |
| Conjunctivae | 16 | 16 | 0 |
| Lacrimal apparatus | 13 | 13 | 0 |
| Stage, no. | |||
| I | 53 | 46 | 7 |
| II | 2 | 2 | 0 |
| III | 0 | 0 | 0 |
| IV | 7 | 7 | 0 |
| Histologic category, no. | |||
| EMZL | 55 | 55 | NA |
| SLL | 2 | NA | 2 |
| DLBCL | 2 | NA | 2 |
| Undetermined | 3 | NA | 3 |
EMZL indicates extranodal marginal zone lymphoma; SLL, small lymphocytic lymphoma; DLBCL, diffuse large B-cell lymphoma; and NA, not applicable.